Structure

Physi-Chem Properties

Molecular Weight:  264.17
Volume:  286.641
LogP:  3.552
LogD:  3.271
LogS:  -4.133
# Rotatable Bonds:  2
TPSA:  43.37
# H-Bond Aceptor:  3
# H-Bond Donor:  0
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.539
Synthetic Accessibility Score:  3.96
Fsp3:  0.75
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.615
MDCK Permeability:  2.2854317649034783e-05
Pgp-inhibitor:  0.99
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.845
30% Bioavailability (F30%):  0.505

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.371
Plasma Protein Binding (PPB):  83.53325653076172%
Volume Distribution (VD):  0.891
Pgp-substrate:  20.95697021484375%

ADMET: Metabolism

CYP1A2-inhibitor:  0.819
CYP1A2-substrate:  0.733
CYP2C19-inhibitor:  0.929
CYP2C19-substrate:  0.903
CYP2C9-inhibitor:  0.732
CYP2C9-substrate:  0.117
CYP2D6-inhibitor:  0.113
CYP2D6-substrate:  0.078
CYP3A4-inhibitor:  0.857
CYP3A4-substrate:  0.546

ADMET: Excretion

Clearance (CL):  6.095
Half-life (T1/2):  0.361

ADMET: Toxicity

hERG Blockers:  0.046
Human Hepatotoxicity (H-HT):  0.644
Drug-inuced Liver Injury (DILI):  0.108
AMES Toxicity:  0.11
Rat Oral Acute Toxicity:  0.306
Maximum Recommended Daily Dose:  0.719
Skin Sensitization:  0.947
Carcinogencity:  0.447
Eye Corrosion:  0.396
Eye Irritation:  0.213
Respiratory Toxicity:  0.884

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC20025

Natural Product ID:  NPC20025
Common Name*:   Methyl Aignopsanoate
IUPAC Name:   methyl (2Z)-2-[(4aR,5S,8aS)-4a,5,8a-trimethyl-1-oxo-3,4,5,6,7,8-hexahydronaphthalen-2-ylidene]acetate
Synonyms:   Methyl Aignopsanoate
Standard InCHIKey:  CJQOKVDQHHONIF-USYVDOKNSA-N
Standard InCHI:  InChI=1S/C16H24O3/c1-11-6-5-8-16(3)14(18)12(10-13(17)19-4)7-9-15(11,16)2/h10-11H,5-9H2,1-4H3/b12-10-/t11-,15+,16+/m0/s1
SMILES:  COC(=O)/C=C1/CC[C@]2([C@](C1=O)(C)CCC[C@@H]2C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1934280
PubChem CID:   42631651
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0001093] Carboxylic acid derivatives
          • [CHEMONTID:0001238] Carboxylic acid esters
            • [CHEMONTID:0003628] Alpha,beta-unsaturated carboxylic esters
              • [CHEMONTID:0003626] Enoate esters

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19376 Cacospongia mycofijiensis Species Thorectidae Eukaryota n.a. n.a. n.a. PMID[18942825]
NPO19376 Cacospongia mycofijiensis Species Thorectidae Eukaryota n.a. Tongan n.a. PMID[19877653]
NPO19376 Cacospongia mycofijiensis Species Thorectidae Eukaryota n.a. n.a. n.a. PMID[22129061]
NPO19376 Cacospongia mycofijiensis Species Thorectidae Eukaryota n.a. n.a. n.a. PMID[30371079]
NPO19376 Cacospongia mycofijiensis Species Thorectidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT139 Cell Line HT-29 Homo sapiens IC50 > 2.5 ug.mL-1 PMID[516135]
NPT400 Cell Line MDA-MB-435 Homo sapiens IC50 > 2.5 ug.mL-1 PMID[516135]
NPT466 Cell Line U-937 Homo sapiens IC50 > 2.5 ug.mL-1 PMID[516135]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 2.5 ug.mL-1 PMID[516135]
NPT471 Organism Trypanosoma brucei brucei Trypanosoma brucei brucei IC50 > 10.0 ug.mL-1 PMID[516135]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC20025 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9296 High Similarity NPC65650
0.8947 High Similarity NPC94200
0.8873 High Similarity NPC133253
0.8873 High Similarity NPC21944
0.8831 High Similarity NPC474976
0.8831 High Similarity NPC474790
0.8696 High Similarity NPC185587
0.859 High Similarity NPC118423
0.8514 High Similarity NPC476346
0.8493 Intermediate Similarity NPC276336
0.8493 Intermediate Similarity NPC180015
0.8493 Intermediate Similarity NPC130016
0.8493 Intermediate Similarity NPC56747
0.8493 Intermediate Similarity NPC109576
0.8462 Intermediate Similarity NPC268122
0.8462 Intermediate Similarity NPC200513
0.84 Intermediate Similarity NPC40353
0.8375 Intermediate Similarity NPC189311
0.8333 Intermediate Similarity NPC40228
0.8312 Intermediate Similarity NPC190211
0.8289 Intermediate Similarity NPC472300
0.8272 Intermediate Similarity NPC168248
0.825 Intermediate Similarity NPC475100
0.825 Intermediate Similarity NPC149869
0.8194 Intermediate Similarity NPC155198
0.8193 Intermediate Similarity NPC474844
0.8182 Intermediate Similarity NPC105197
0.8171 Intermediate Similarity NPC477228
0.8171 Intermediate Similarity NPC163016
0.8171 Intermediate Similarity NPC75315
0.8158 Intermediate Similarity NPC4509
0.8158 Intermediate Similarity NPC27205
0.8158 Intermediate Similarity NPC19907
0.8158 Intermediate Similarity NPC473223
0.8148 Intermediate Similarity NPC65661
0.8148 Intermediate Similarity NPC86316
0.8148 Intermediate Similarity NPC106416
0.8095 Intermediate Similarity NPC476437
0.8095 Intermediate Similarity NPC51486
0.8095 Intermediate Similarity NPC476369
0.8049 Intermediate Similarity NPC220478
0.8 Intermediate Similarity NPC472867
0.8 Intermediate Similarity NPC469805
0.8 Intermediate Similarity NPC469806
0.8 Intermediate Similarity NPC469804
0.8 Intermediate Similarity NPC469799
0.8 Intermediate Similarity NPC472239
0.7976 Intermediate Similarity NPC5509
0.7975 Intermediate Similarity NPC469797
0.7975 Intermediate Similarity NPC469798
0.7973 Intermediate Similarity NPC265782
0.7973 Intermediate Similarity NPC251929
0.7973 Intermediate Similarity NPC2634
0.7971 Intermediate Similarity NPC127582
0.7949 Intermediate Similarity NPC471220
0.7949 Intermediate Similarity NPC470052
0.7949 Intermediate Similarity NPC198240
0.7945 Intermediate Similarity NPC188292
0.7945 Intermediate Similarity NPC260474
0.7901 Intermediate Similarity NPC279639
0.7901 Intermediate Similarity NPC3856
0.7901 Intermediate Similarity NPC193198
0.7901 Intermediate Similarity NPC22611
0.7887 Intermediate Similarity NPC329698
0.7882 Intermediate Similarity NPC8062
0.7875 Intermediate Similarity NPC229584
0.7875 Intermediate Similarity NPC90055
0.7875 Intermediate Similarity NPC14203
0.7867 Intermediate Similarity NPC181587
0.7867 Intermediate Similarity NPC54123
0.7857 Intermediate Similarity NPC226863
0.7857 Intermediate Similarity NPC196407
0.7857 Intermediate Similarity NPC472302
0.7838 Intermediate Similarity NPC139397
0.7831 Intermediate Similarity NPC472863
0.7821 Intermediate Similarity NPC165711
0.7821 Intermediate Similarity NPC97377
0.7821 Intermediate Similarity NPC61952
0.7821 Intermediate Similarity NPC470557
0.7816 Intermediate Similarity NPC476415
0.7805 Intermediate Similarity NPC474359
0.7805 Intermediate Similarity NPC16287
0.7805 Intermediate Similarity NPC178025
0.7805 Intermediate Similarity NPC30486
0.7805 Intermediate Similarity NPC181743
0.7792 Intermediate Similarity NPC244166
0.7792 Intermediate Similarity NPC469803
0.7791 Intermediate Similarity NPC177037
0.7791 Intermediate Similarity NPC472814
0.7778 Intermediate Similarity NPC142253
0.7778 Intermediate Similarity NPC186276
0.7778 Intermediate Similarity NPC251118
0.7778 Intermediate Similarity NPC3511
0.7778 Intermediate Similarity NPC107258
0.7765 Intermediate Similarity NPC251528
0.7765 Intermediate Similarity NPC174342
0.7765 Intermediate Similarity NPC284561
0.7763 Intermediate Similarity NPC474228
0.7763 Intermediate Similarity NPC144947
0.7763 Intermediate Similarity NPC303613
0.7746 Intermediate Similarity NPC197238
0.7746 Intermediate Similarity NPC288253
0.7746 Intermediate Similarity NPC202118
0.7733 Intermediate Similarity NPC260040
0.7733 Intermediate Similarity NPC307176
0.7727 Intermediate Similarity NPC209355
0.7722 Intermediate Similarity NPC59436
0.7711 Intermediate Similarity NPC60350
0.7703 Intermediate Similarity NPC310992
0.7703 Intermediate Similarity NPC87141
0.7701 Intermediate Similarity NPC472871
0.7701 Intermediate Similarity NPC139692
0.7701 Intermediate Similarity NPC469939
0.7692 Intermediate Similarity NPC474463
0.7692 Intermediate Similarity NPC469796
0.7692 Intermediate Similarity NPC469793
0.7692 Intermediate Similarity NPC180886
0.7683 Intermediate Similarity NPC469
0.7681 Intermediate Similarity NPC60772
0.7674 Intermediate Similarity NPC159748
0.7674 Intermediate Similarity NPC101651
0.7674 Intermediate Similarity NPC471818
0.7662 Intermediate Similarity NPC166797
0.7662 Intermediate Similarity NPC329866
0.7662 Intermediate Similarity NPC309852
0.7662 Intermediate Similarity NPC474797
0.7662 Intermediate Similarity NPC474796
0.7654 Intermediate Similarity NPC475833
0.7654 Intermediate Similarity NPC278459
0.7654 Intermediate Similarity NPC282293
0.7647 Intermediate Similarity NPC472870
0.7647 Intermediate Similarity NPC215831
0.7639 Intermediate Similarity NPC52449
0.7639 Intermediate Similarity NPC285371
0.7639 Intermediate Similarity NPC469662
0.7639 Intermediate Similarity NPC475124
0.7639 Intermediate Similarity NPC212210
0.7639 Intermediate Similarity NPC169275
0.7632 Intermediate Similarity NPC190035
0.7632 Intermediate Similarity NPC257618
0.7632 Intermediate Similarity NPC474562
0.7625 Intermediate Similarity NPC476177
0.7625 Intermediate Similarity NPC150646
0.7625 Intermediate Similarity NPC263951
0.7625 Intermediate Similarity NPC471299
0.7614 Intermediate Similarity NPC470697
0.7614 Intermediate Similarity NPC84893
0.7606 Intermediate Similarity NPC60565
0.76 Intermediate Similarity NPC256846
0.7595 Intermediate Similarity NPC316500
0.759 Intermediate Similarity NPC87552
0.7586 Intermediate Similarity NPC473986
0.7586 Intermediate Similarity NPC474018
0.7586 Intermediate Similarity NPC303697
0.7586 Intermediate Similarity NPC477783
0.7586 Intermediate Similarity NPC473944
0.7571 Intermediate Similarity NPC472304
0.7571 Intermediate Similarity NPC276764
0.7568 Intermediate Similarity NPC4370
0.7568 Intermediate Similarity NPC290350
0.7561 Intermediate Similarity NPC302661
0.7561 Intermediate Similarity NPC100297
0.7561 Intermediate Similarity NPC16321
0.7561 Intermediate Similarity NPC238991
0.7561 Intermediate Similarity NPC142683
0.7561 Intermediate Similarity NPC178676
0.7558 Intermediate Similarity NPC73995
0.7558 Intermediate Similarity NPC285982
0.7556 Intermediate Similarity NPC253826
0.7556 Intermediate Similarity NPC474343
0.7532 Intermediate Similarity NPC251705
0.7531 Intermediate Similarity NPC195424
0.7531 Intermediate Similarity NPC267517
0.7529 Intermediate Similarity NPC181327
0.7529 Intermediate Similarity NPC476293
0.7529 Intermediate Similarity NPC476409
0.7528 Intermediate Similarity NPC33473
0.75 Intermediate Similarity NPC159577
0.75 Intermediate Similarity NPC239098
0.75 Intermediate Similarity NPC475657
0.75 Intermediate Similarity NPC128276
0.75 Intermediate Similarity NPC474680
0.75 Intermediate Similarity NPC115515
0.75 Intermediate Similarity NPC115021
0.75 Intermediate Similarity NPC323765
0.75 Intermediate Similarity NPC74410
0.75 Intermediate Similarity NPC242069
0.75 Intermediate Similarity NPC177932
0.75 Intermediate Similarity NPC476416
0.75 Intermediate Similarity NPC35734
0.75 Intermediate Similarity NPC472303
0.75 Intermediate Similarity NPC217394
0.75 Intermediate Similarity NPC282593
0.75 Intermediate Similarity NPC110405
0.75 Intermediate Similarity NPC8571
0.7473 Intermediate Similarity NPC316598
0.7473 Intermediate Similarity NPC57079
0.7473 Intermediate Similarity NPC108368
0.7471 Intermediate Similarity NPC152467
0.7471 Intermediate Similarity NPC477782

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC20025 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8462 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7973 Intermediate Similarity NPD4691 Approved
0.7838 Intermediate Similarity NPD4137 Phase 3
0.7733 Intermediate Similarity NPD4747 Approved
0.7662 Intermediate Similarity NPD4058 Approved
0.75 Intermediate Similarity NPD1694 Approved
0.7412 Intermediate Similarity NPD6684 Approved
0.7412 Intermediate Similarity NPD7334 Approved
0.7412 Intermediate Similarity NPD7521 Approved
0.7412 Intermediate Similarity NPD7146 Approved
0.7412 Intermediate Similarity NPD6409 Approved
0.7412 Intermediate Similarity NPD5330 Approved
0.7403 Intermediate Similarity NPD5276 Approved
0.7386 Intermediate Similarity NPD5693 Phase 1
0.7326 Intermediate Similarity NPD3573 Approved
0.7241 Intermediate Similarity NPD6672 Approved
0.7241 Intermediate Similarity NPD5737 Approved
0.7241 Intermediate Similarity NPD6903 Approved
0.7241 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7237 Intermediate Similarity NPD3621 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD4687 Approved
0.7215 Intermediate Similarity NPD5733 Approved
0.7125 Intermediate Similarity NPD8039 Approved
0.7108 Intermediate Similarity NPD4695 Discontinued
0.7045 Intermediate Similarity NPD5208 Approved
0.6966 Remote Similarity NPD6673 Approved
0.6966 Remote Similarity NPD6080 Approved
0.6966 Remote Similarity NPD6904 Approved
0.6944 Remote Similarity NPD287 Approved
0.6941 Remote Similarity NPD5209 Approved
0.6933 Remote Similarity NPD5325 Clinical (unspecified phase)
0.6848 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6848 Remote Similarity NPD7748 Approved
0.6848 Remote Similarity NPD7900 Approved
0.6824 Remote Similarity NPD8028 Phase 2
0.6818 Remote Similarity NPD6098 Approved
0.6818 Remote Similarity NPD4519 Discontinued
0.6818 Remote Similarity NPD4623 Approved
0.6813 Remote Similarity NPD7515 Phase 2
0.6782 Remote Similarity NPD3666 Approved
0.6782 Remote Similarity NPD3133 Approved
0.6782 Remote Similarity NPD3665 Phase 1
0.6774 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6744 Remote Similarity NPD4221 Approved
0.6744 Remote Similarity NPD4223 Phase 3
0.6737 Remote Similarity NPD4225 Approved
0.6737 Remote Similarity NPD7638 Approved
0.6703 Remote Similarity NPD5692 Phase 3
0.6703 Remote Similarity NPD5785 Approved
0.6703 Remote Similarity NPD5207 Approved
0.6702 Remote Similarity NPD7732 Phase 3
0.67 Remote Similarity NPD6686 Approved
0.6667 Remote Similarity NPD6001 Approved
0.6667 Remote Similarity NPD4194 Approved
0.6667 Remote Similarity NPD4192 Approved
0.6667 Remote Similarity NPD3527 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7639 Approved
0.6667 Remote Similarity NPD4193 Approved
0.6667 Remote Similarity NPD4191 Approved
0.6667 Remote Similarity NPD7640 Approved
0.6632 Remote Similarity NPD7902 Approved
0.6632 Remote Similarity NPD6084 Phase 2
0.6632 Remote Similarity NPD6083 Phase 2
0.663 Remote Similarity NPD5694 Approved
0.663 Remote Similarity NPD6050 Approved
0.6629 Remote Similarity NPD3618 Phase 1
0.6623 Remote Similarity NPD2685 Clinical (unspecified phase)
0.6596 Remote Similarity NPD5695 Phase 3
0.6593 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6591 Remote Similarity NPD4197 Approved
0.6562 Remote Similarity NPD5696 Approved
0.6559 Remote Similarity NPD6399 Phase 3
0.6552 Remote Similarity NPD3667 Approved
0.6517 Remote Similarity NPD5329 Approved
0.6471 Remote Similarity NPD3617 Approved
0.6471 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6452 Remote Similarity NPD5281 Approved
0.6452 Remote Similarity NPD5284 Approved
0.6452 Remote Similarity NPD6079 Approved
0.6444 Remote Similarity NPD4138 Approved
0.6444 Remote Similarity NPD4693 Phase 3
0.6444 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6444 Remote Similarity NPD5690 Phase 2
0.6444 Remote Similarity NPD5205 Approved
0.6444 Remote Similarity NPD4688 Approved
0.6444 Remote Similarity NPD4689 Approved
0.6444 Remote Similarity NPD4690 Approved
0.6444 Remote Similarity NPD5279 Phase 3
0.6413 Remote Similarity NPD5328 Approved
0.6413 Remote Similarity NPD4753 Phase 2
0.6413 Remote Similarity NPD6051 Approved
0.6404 Remote Similarity NPD4786 Approved
0.6404 Remote Similarity NPD3668 Phase 3
0.6355 Remote Similarity NPD7115 Discovery
0.6354 Remote Similarity NPD7614 Phase 1
0.6275 Remote Similarity NPD5697 Approved
0.6264 Remote Similarity NPD5280 Approved
0.6264 Remote Similarity NPD4694 Approved
0.625 Remote Similarity NPD5210 Approved
0.625 Remote Similarity NPD5654 Approved
0.625 Remote Similarity NPD1698 Clinical (unspecified phase)
0.625 Remote Similarity NPD4629 Approved
0.6222 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6214 Remote Similarity NPD6881 Approved
0.6214 Remote Similarity NPD6011 Approved
0.6214 Remote Similarity NPD6899 Approved
0.6211 Remote Similarity NPD4202 Approved
0.6207 Remote Similarity NPD4195 Approved
0.6186 Remote Similarity NPD5222 Approved
0.6186 Remote Similarity NPD5221 Approved
0.6186 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6176 Remote Similarity NPD6402 Approved
0.6176 Remote Similarity NPD7128 Approved
0.6176 Remote Similarity NPD5739 Approved
0.6176 Remote Similarity NPD6008 Approved
0.6176 Remote Similarity NPD6675 Approved
0.617 Remote Similarity NPD6698 Approved
0.617 Remote Similarity NPD46 Approved
0.6163 Remote Similarity NPD4756 Discovery
0.6162 Remote Similarity NPD6404 Discontinued
0.6154 Remote Similarity NPD6012 Approved
0.6154 Remote Similarity NPD5363 Approved
0.6154 Remote Similarity NPD6013 Approved
0.6154 Remote Similarity NPD6014 Approved
0.6139 Remote Similarity NPD6052 Approved
0.6125 Remote Similarity NPD7331 Phase 2
0.6122 Remote Similarity NPD5173 Approved
0.6122 Remote Similarity NPD5959 Approved
0.6117 Remote Similarity NPD5701 Approved
0.6117 Remote Similarity NPD6614 Approved
0.6117 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6111 Remote Similarity NPD4788 Approved
0.6105 Remote Similarity NPD7637 Suspended
0.6095 Remote Similarity NPD7102 Approved
0.6095 Remote Similarity NPD7290 Approved
0.6095 Remote Similarity NPD6883 Approved
0.6058 Remote Similarity NPD7320 Approved
0.604 Remote Similarity NPD7632 Discontinued
0.604 Remote Similarity NPD5211 Phase 2
0.6038 Remote Similarity NPD6617 Approved
0.6038 Remote Similarity NPD8130 Phase 1
0.6038 Remote Similarity NPD6847 Approved
0.6038 Remote Similarity NPD6650 Approved
0.6038 Remote Similarity NPD6649 Approved
0.6038 Remote Similarity NPD6869 Approved
0.602 Remote Similarity NPD4697 Phase 3
0.6 Remote Similarity NPD4696 Approved
0.6 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6 Remote Similarity NPD5286 Approved
0.6 Remote Similarity NPD6372 Approved
0.6 Remote Similarity NPD4096 Approved
0.6 Remote Similarity NPD5285 Approved
0.6 Remote Similarity NPD6373 Approved
0.5981 Remote Similarity NPD6882 Approved
0.5981 Remote Similarity NPD8297 Approved
0.5978 Remote Similarity NPD1733 Clinical (unspecified phase)
0.5978 Remote Similarity NPD7520 Clinical (unspecified phase)
0.5972 Remote Similarity NPD6927 Phase 3
0.596 Remote Similarity NPD3495 Discontinued
0.596 Remote Similarity NPD4755 Approved
0.5955 Remote Similarity NPD8259 Clinical (unspecified phase)
0.5943 Remote Similarity NPD5955 Clinical (unspecified phase)
0.5941 Remote Similarity NPD5223 Approved
0.5938 Remote Similarity NPD6411 Approved
0.5934 Remote Similarity NPD5362 Discontinued
0.5926 Remote Similarity NPD6108 Clinical (unspecified phase)
0.5926 Remote Similarity NPD4632 Approved
0.5922 Remote Similarity NPD5909 Discontinued
0.5922 Remote Similarity NPD5141 Approved
0.5895 Remote Similarity NPD1695 Approved
0.5888 Remote Similarity NPD6401 Clinical (unspecified phase)
0.5882 Remote Similarity NPD5225 Approved
0.5882 Remote Similarity NPD5224 Approved
0.5882 Remote Similarity NPD5226 Approved
0.5882 Remote Similarity NPD4633 Approved
0.5876 Remote Similarity NPD5779 Approved
0.5876 Remote Similarity NPD5778 Approved
0.5842 Remote Similarity NPD4700 Approved
0.5825 Remote Similarity NPD5175 Approved
0.5825 Remote Similarity NPD5174 Approved
0.5824 Remote Similarity NPD4270 Approved
0.5824 Remote Similarity NPD4269 Approved
0.5818 Remote Similarity NPD6868 Approved
0.5818 Remote Similarity NPD6274 Approved
0.581 Remote Similarity NPD6412 Phase 2
0.5806 Remote Similarity NPD1696 Phase 3
0.5802 Remote Similarity NPD7341 Phase 2
0.5794 Remote Similarity NPD6371 Approved
0.5789 Remote Similarity NPD4518 Approved
0.578 Remote Similarity NPD6858 Approved
0.578 Remote Similarity NPD7094 Approved
0.5778 Remote Similarity NPD4252 Approved
0.5773 Remote Similarity NPD8034 Phase 2
0.5773 Remote Similarity NPD8035 Phase 2
0.5766 Remote Similarity NPD6317 Approved
0.5766 Remote Similarity NPD6009 Approved
0.5765 Remote Similarity NPD5777 Approved
0.5761 Remote Similarity NPD7154 Phase 3
0.5745 Remote Similarity NPD5786 Approved
0.5732 Remote Similarity NPD4224 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data